Edition:
India

Insider Trading: BioXcel Therapeutics Inc (BTAI.OQ)

BTAI.OQ on NASDAQ Stock Exchange Capital Market

10.85USD
24 May 2019
Change (% chg)

$0.81 (+8.07%)
Prev Close
$10.04
Open
$9.89
Day's High
$10.97
Day's Low
$9.89
Volume
7,292
Avg. Vol
11,315
52-wk High
$14.28
52-wk Low
$2.41

All Insider Trades
Trading Date Name Title Type Shares Traded Price
14 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 200 $4.32
14 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 100 $4.50
14 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 400 $4.49
14 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 500 $4.48
14 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 800 $4.27
7 Dec 2018

Mueller (Peter)

Director Buy 495 $5.00
7 Dec 2018

Mueller (Peter)

Director Buy 6,905 $5.01
6 Dec 2018

Mueller (Peter)

Director Buy 100 $5.01
6 Dec 2018

Mueller (Peter)

Director Buy 1,295 $5.00
4 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 500 $5.15
4 Dec 2018

Mueller (Peter)

Director Buy 2,062 $5.15
4 Dec 2018

Mueller (Peter)

Director Buy 1,076 $5.09
4 Dec 2018

Mueller (Peter)

Director Buy 344 $5.12
4 Dec 2018

Mueller (Peter)

Director Buy 200 $5.13
4 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 500 $5.09
4 Dec 2018

Mueller (Peter)

Director Buy 325 $5.11
4 Dec 2018

Yocca (Frank D. Ph.D.)

Officer Buy 450 $5.20
3 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 100 $5.13
3 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 200 $5.10
3 Dec 2018

Steinhart (Richard I)

Chief Financial Officer Buy 500 $5.20
3 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 100 $5.14
3 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 500 $5.20
3 Dec 2018

Yocca (Frank D. Ph.D.)

Officer Buy 450 $5.23
3 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 100 $5.18
30 Nov 2018

Steinhart (Richard I)

Chief Financial Officer Buy 500 $5.00

Institutional Holders

% Shares Owned: 21.16%
# of Holders: 24
Total Shares Held: 3,314,552
3 Mo. Net Change: 90,130
# New Positions: 9
# Closed Positions: 2
# Increased Positions: 15
# Reduced Positions: 7
# Net Buyers: 8

Officers & Directors

Name Age Since Current Position

Peter Mueller

61 2017 Independent Chairman of the Board

Vimal Mehta

57 2017 President, Chief Executive Officer, Secretary, Director

Richard Steinhart

61 2017 Chief Financial Officer

Frank Yocca

62 2017 Chief Scientific Officer

Chids Mahadevan

46 2017 Vice President - Finance

Luca Rastelli

50 2017 Vice President - Oncology R&D

Robert Risinger

2019 Vice President Clinical Development

Vikas Sharma

2018 Vice President - Business Development

Vincent O'Neill

2017 Chief Medical Officer

Krishnan Nandabalan

55 2017 Director

Sandeep Laumas

50 2017 Independent Director

Michal Votruba

53 2019 Independent Director